Changes in Function and Expression Level of Multidrug Resistance-Associated Protein during Intestinal Ischemia/Reperfusion
Journal Title: Scholars Journal of Applied Medical Sciences - Year 2018, Vol 7, Issue 2
Abstract
Abstract: Ischemic bowel disease is induced by poor circulation of blood, and thus oxygen and nutrition necessary for the small intestine are not supplied enough. As a result, such condition causes inflammation and ulcers, such as ischemic colitis and acute mesenteric arterial occlusion. We previously reported changes in function and expression level of P-glycoprotein (P-gp) which is a typical and important ABC transporter in the small intestine, liver and kidney during intestinal ischemia/reperfusion (I/R). In this study, we examined I/R-induced changes in multidrug resistance-associated proteins (Mrps) which is also an important ABC transporter like P-gp. The superior mesenteric vein and artery in rat were occluded by hanging itself using surgical-sutures connected with the spring balance for 60 min, followed by a reperfusion. The excretion clearances to jejunal lumen (CLjejunum), bile (CLbile) and urine (CLurine) of 5(6)-carboxyfluorescein (5-CF) diacetate (5-CFDA), a Mrp substrate, were determined after i.v. administration of 5-CFDA. We also investigated changes in the protein and mRNA expression levels of Mrp2 during intestinal I/R. It was shown that the expression behavior of Mrp2 is different depending on each organ during intestinal I/R. For the function of Mrp, during early term of reperfusion, the total clearance (CLtot) of 5-CFDA (5-CF) was significantly decreased by intestinal ischemia compared with the control condition. However, the behavior of excretion clearance was differ depending on each organ. In longer term of reperfusion, CLtot of 5-CFDA (5-CF) of intestinal I/R condition was converged to the control level until 24 hr after reperfusion. Intestinal I/R change the function and expression level of intestinal Mrp2 as well as hepatic and renal Mrp2. Therefore, when performing drug therapy to the ischemic bowel disease, the caution is necessary for the dosing of Mrp2 substrates.
Authors and Affiliations
Yusuke Takizawa, Nasa Sakamoto, Masahiro Hayashi
Keywords
Related Articles
- EP ID EP479689
- DOI -
- Views 100
- Downloads 0
Clinical, Laboratory, Radiological & Autopsy Correlation In Brain Tuberculosis
Abstract: Tuberculosis is a major health problem in developing countries. A significant number of patients admitted to the hospitals in our country succumb to tuberculosis of the brain. Central nervous system tuberculosi...
Accuracy of the Prehospital Diagnosis of Pelvic Fractures Diagnosed by Traumatic PAN Scans
Abstract: We retrospectively investigated the accuracy of the diagnosis of pelvic fracture (PF) by emergency medical technicians (EMTs).From April 2012 to March 2017, we performed a retrospective medical chart review of...
Role of Brain-Derived Neurotrophic Factor on Cognition of Hypothyroid Neonatal Rats
Mechanisms underlying the effects of inadequate thyroid hormone availability to the brain, on cognitive functions are not completely understood. The aim of this study is to assess if dysregulation of Brain derived neurot...
A Clinical and Study and Management of Idiopathic Hypertrophic Pyloric Stenosis
Idiopathic Hypertrophic Pyloric Stenosis (IHPS) is one of the causes for vomiting in the newborn. The treatment of this condition had high mortality and morbidity until Ramstedt’s showed that pyloromyotomy surgery was cu...
Effect of Short-Term Smoking Cessation Intervention on Abdominal Operations
Smoking of tobacco has been practiced by people all over the world cutting across national and social barriers. The increasing habit of smoking has resulted in a high incidence of tobacco related diseases all over the d...